ANNOUNCEMENT EURONEXT N.V. (“Euronext” or the “Offeror”) announces the successful outcome of its voluntary share exchange tender offer made to acquire the ordinary registered shares of HELLENIC EXCHANGES – ATHENS STOCK EXCHANGE S.A. (“ATHEX”) 19 November 2025 INTRODUCTION In accordance with article 23 of Greek Law 3461/2006, as amended and in force (the “Law”), Euronext announces the successful outcome of its voluntary share exchange tender offer (the “Tender Offer”), which it submitted on 30 July 2025, to acquire all the ordinary registered shares, each having a nominal value of €0.42 (“ATHEX Share”) issued by ATHEX, which Euronext and any “persons acting in concert” (as defined in article 2(e) of the Law) with Euronext, do not hold directly or indirectly, in consideration for new Euro denominated ordinary shares issued by Euronext with...

Euronext announces the success of the voluntary share exchange tender offer to acquire ATHEX GroupStrong shareholder support reflects confidence in the future growth trajectory of Euronext ATHEX to join Euronext’s best-in-class trading and post-trade technology, boosting the visibility and attractiveness of the Greek market on an international scale This result reinforces Euronext’s leadership in Europe and advances the Group’s diversification strategyAmsterdam, Brussels, Dublin, Lisbon, Milan, Oslo and Paris – 19 November 2025 – Euronext, the leading European capital market infrastructure, announces the success of the voluntary share exchange tender offer (“Tender Offer”) for HELLENIC EXCHANGES-ATHEX STOCK EXCHANGE S.A. (“ATHEX”), the parent company of ATHEX Group. During the Acceptance Period1, which lasted six weeks and ended...

Please find below a press release from Aedifica (a public regulated real estate company under Belgian law, listed on Euronext Brussels and Euronext Amsterdam), regarding the development of 4 care homes in Turku, Seinäjoki and Kuopio (Finland) for a total amount of €21 million.AttachmentsPress release ENCommuniqué de presse FRPersbericht NL

LOS ANGELES, Nov. 19, 2025 (GLOBE NEWSWIRE) — iPR Software, Inc., https://www.iprsoftware.com/, a Software as a Service (SaaS) company that utilizes AI-driven digital solutions for PR and Marketing professionals, announced today that Eric Schwartzman, the founder of iPressroom and a pioneer in the digital software industry, has sold his remaining minority interest in the company.  “We are grateful to Eric for his vision in founding our company and wish him continued success,” said J.D. Bowles President & CEO.  “He has been an industry champion and served many roles throughout the digital media transformation.” “I happened to be in the right place at the right time, and I saw something starting to shift,” said Schwartzman. “I’ve always had a knack for spotting change early, and...

WETHERSFIELD, Conn., Nov. 19, 2025 (GLOBE NEWSWIRE) — To say Mark Flannery’s first full year in business as the owner of Minuteman Press in Wethersfield, CT was productive is an understatement. Mark purchased the business in November of 2024. In just one year, Mark has grown his Minuteman Press franchise by leveraging his background in marketing and sales, making inroads in the community, and hiring the right staff. As a result, Mark and his team won the Business of the Year Award from the Wethersfield Chamber of Commerce. To wrap up his first year, Mark has also completed a key acquisition of 42-year print shop Academy Printing.Journey to Minuteman Press & Celebrating One Year Prior to Minuteman Press, Mark shares, “My background is in marketing and sales support for large corporations. I was looking at a few different...

Company to open-source RTL, chips, and tools to catalyze community-driven innovation in AI inference SAN FRANCISCO, Nov. 19, 2025 (GLOBE NEWSWIRE) — Ainekko, a startup pioneering open, software-defined AI infrastructure, today announced the acquisition of all intellectual property and select assets from Esperanto Technologies, including chip designs, software tooling, and development frameworks. The acquisition marks a major step toward Ainekko’s goal of making advanced AI infrastructure open, accessible, and adaptable, starting at the silicon level. By releasing a production-grade, many-core RISC-V architecture to the public, including RTL, reference designs, and development tools, Ainekko is laying the foundation for a new era of community-driven hardware innovation. The platform is designed to empower developers, researchers,...

All-stock acquisition includes clinical-stage CD19/BCMA Dual-CAR T program Acquisition will expand existing advanced clinical-stage pipeline of amezalpat (PPAR⍺ Antagonist, Phase 3-ready) and TPST-1495 (Dual Ep2/4 Antagonist, Phase 2 start expected near term) The anticipated preclosing equity financing and an investment commitment from Factor Bioscience is expected to extend Tempest’s runway to mid 2027 and through potentially significant milestones Plan to proceed with execution of globally approved protocol for amezalpat in first-line HCC subject to additional resources or partnerships Matt Angel, Ph.D. to assume role of President and CEO and Stephen Brady to assume role of Chairman of the board of directors upon closing of the acquisitionBRISBANE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) — In a transaction designed to both...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY ASSET MANAGEMENT LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IQE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree IDOX PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

500+ person global organization spans 25+ countries with operations across North America, Europe, Africa, Latin America, and Asia-PacificP95 and Julius ClinicalMerger to Form Global, Science-Led CRO Delivering Integrated Clinical Development and Real-World EvidenceLeuven, Belgium and Zeist, The Netherlands, Nov. 19, 2025 (GLOBE NEWSWIRE) — P95 and Julius Clinical today announced that they have merged to form a leading global, full-service clinical research organization (CRO) with integrated expertise across neuroscience, cardio-renal-metabolic, and infectious diseases and vaccines. The combined organization includes more than 500 professionals in over 25 countries and delivers clinical development and real-world evidence (RWE) programs across five continents. This merger brings together the complementary strengths of...